• Artemisinin, Artemisia Annual L, Artemisinin 99%
  • Artemisinin, Artemisia Annual L, Artemisinin 99%
  • Artemisinin, Artemisia Annual L, Artemisinin 99%
  • Artemisinin, Artemisia Annual L, Artemisinin 99%
  • Artemisinin, Artemisia Annual L, Artemisinin 99%
  • Artemisinin, Artemisia Annual L, Artemisinin 99%

Artemisinin, Artemisia Annual L, Artemisinin 99%

Certification: ISO
Assay Method: HPLC, UV
Application Form: Paste
Application: Food, Health Care Products, Medicine
State: Powder
Extract Source: Artemisinin
Customization:

Contact Supplier

Gold Member Since 2019

Suppliers with verified business licenses

Rating: 5.0/5
Trading Company

Basic Info.

Model NO.
food grade
Test Method
HPLC
Store
Dry and Cool Place
CAS No.
63968-64-9
En No.
1806241-263-5
M F
C15h22o5
M G
282.33
Transport Package
25kg/Drum
Specification
Food grade
Trademark
JK
Origin
China
HS Code
130231
Production Capacity
100mt/Year

Product Description


Artemisinin

Product Name: Artemisinin 
Botanical Source: Artemisia Annua L. 
Part Used: Leaf 
Specification: Artemisinin 99% HPLC 
Appearance: White crystal Powder

Description

Artemisinin is also known as Qinghaosu and its derivatives are a group of drugs that possess the most rapid action of all current drugs against Plasmodium falciparum malaria.Treatments containing an artemisinin derivative (artemisinin-combination therapies, ACTs) are now standard treatment worldwide for P. falciparum malaria. The starting compound artemisinin is isolated from the plant Artemisia annua, sweet wormwood, a herb employed in Chinese traditional medicine.

Artemisia annua L. is an aromatic-antibacterial herb that destroys malarial parasites, lowers fevers and checks bleeding, and of which the secondary compound of interest is artemisinin. 

Main Function

Antimalarial;

Treat falciparum malaria;

Treat breast tumor.

Dangerous malignant anopheles type.

Antibacterial.

Anti-parasite, Artemisinin play the role of anti-schistosomiasis and leptospirosis.

Application Filed

Artemisinin can be used in Pharmaceutical field ( anti-malarial agents);


Artemisinin, Artemisia Annual L, Artemisinin 99%


 

Artemisinin Basic information
Pharmacology and mechanism of action Indications Side effects Contraindications Preparations Pharmaceutical Applications Drugs for treatment of malaria Chemical properties Uses Production method Category Toxic grading Acute toxicity Flammability and Hazardous properties Storage and transportation characteristics Fire extinguishing agent References
Product Name: Artemisinin
Synonyms: Artemisinin,Artemisinine,Qinghaosu;Artemisinin, 98%, from Artemisia annua;qinghosu;[3r-(3r,5as,6s,8as,9r,10r,12s,12ar**)]-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4,3-j]-1,2-benzodioxepin-10-one;ALPHA BETA ARTEMISININ;ARTEMISINE;ARTEMISIA P E;ARTEMISIA ANNUA
CAS: 63968-64-9
MF: C15H22O5
MW: 282.33
EINECS: 1806241-263-5
Product Categories: reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;Active Pharmaceutical Ingredients;Miscellaneous Natural Products;Antimalarial;Inhibitors;Others (Antibiotics for Research and Experimental Use);Antibiotics for Research and Experimental Use;Biochemistry;Standard extract;Natural Plant Extract;Intermediates & Fine Chemicals;Pharmaceuticals;Miscellaneous Compounds;Chiral Reagents;Heterocycles;Plant extract;sy;Herb extract;API;chemical reagent;pharmaceutical intermediate;phytochemical
Mol File: 63968-64-9.mol
 
 
Artemisinin Chemical Properties
Melting point  156-157 °C(lit.)
alpha  76 º (c=0.5,MeOH)
Boiling point  344.94°C (rough estimate)
density  1.0984 (rough estimate)
refractive index  75 ° (C=0.5, MeOH)
storage temp.  Store at +4°C
solubility  Soluble to 100mM in DMSO and to 75mM in ethanol
form  White to off-white crystalline solid.
color  Needles
optical activity [α]20/D +76°, c = 0.5 in methanol
Merck  14,817
Stability: Stable. Combustible. Incompatible with strong oxidizing agents, acids, acid chlorides, acid anhydrides. May absorb, and react with, carbon dioxide from the air.
 
Safety Information
Safety Statements  22-24/25
WGK Germany  2
RTECS  KD4170000
HS Code  29322985
Toxicity LD50 in mice (mg/kg): 5105 orally; 2800 i.m.; 1558 i.p. (Koch); LD50 in mice, rats (mg/kg): 4228, 5576 orally; 3840, 2571 i.m. (China Cooperative Research Group on Qinghaosu)
 
MSDS Information
Provider Language
(+)-Arteannuin English
SigmaAldrich English
 
Artemisinin Usage And Synthesis
Pharmacology and mechanism of action Artemisinin (qinghaosu) is an antimalarial compound first isolated in pure form in 1972 by Chinese scientists from the herb qinghao (Artemisia annua). This herb (worm wood) has been used in Chinese traditional medicine to control fever for over 2000 years [1]. Artemisinin is a compound with a peculiar structure, low toxicity and high efficacy even in severe chloroquine resistant P. falciparum malaria. Unlike current antimalarial drugs which have a nitrogen-containing heterocylic ring system, it is a sesquiterpene lactone with an endoperoxide linkage. The endoperoxide linkage is essential for the antimalarial activity of the drug. Artemisinin has been shown to be a potent schizontocidal drug both in vitro and in experimental animal models, but it has no practical effect against the exoerythrocytic tissue phase, the sporozoites and the gametocytes[2].

The mechanism of action of artemisinin is not clearly understood. The drug selectively concentrates in parasitized cells by reacting with the intraparasitic hemin (hemozoin). In vitro this reaction appears to generate toxic organic free radicals causing damage to parasite membranes [2-4]. The derivatives of artemisinin are more potent than the parent drug and have apparently a similar mechanism of action [1,2].
Indications Artemisinin and its derivatives are valuable drugs for the management of malaria. They should not be used unnecessarily or with incomplete dosage regimens. They are indicated only in areas where multidrug resistant P. falciparum malaria is prevalent [5].
 
Side effects Artemisinin and its derivatives are exceptionally safe drugs. Millions of people have taken them and serious side effects have yet to be reported. The most commonly reported side effects include mild and transient gastrointestinal problems (such as nausea, vomiting, abdominal pain and diarrhoea), headache, and dizziness particularly after oral administration. Transient first degree heart block and bradycardia were reported in a few individuals, who received artesunate or artemether at the standard doses. Brief episodes of drug-induced fever have also been observed in a few studies [6,5]. After rectal administration the patients may experience tenesmus, abdominal pain and diarrhoea. A transient dose-related decrease in circulating reticulocytes has been reported following high doses of artesunate above 4 mg/kg for 3 days. All values returned to pre-treatment values within 14 days [6,5]. Neurotoxicity has been observed in animal studies but has never been documented in man [7].
 
Contraindications There are no known contraindications. However, artemisinin and its derivatives should only be used when other antimalarial drugs do not work.
 
Preparations Artemether
? Paluther® (Rhône-Poulenc Rorer). Solution for injection 80 mg/ml.
? Artenam® (Dragon Pharmaceuticals Ltd, Wales UK). Solution for injection 100 mg/ml.
 
Several other preparations containing artemisinin derivatives are manufactured in China and Vietnam. The availability of these preparations is presently uncertain.
Pharmaceutical Applications The genus Artemisia of the family Asteraceae is comprised of more than 500 species which are found all over the world. Many members of the genus are used in various traditional therapies including East Asian medicine and Ayurveda. Some important species which have been studied for their various therapeutic potentials are A. asiatica for inflammation, infection, and ulcerogenic disorders; A. annua for fevers specially malaria; A. afra for cough, cold, headache, dyspepsia, colic, diabetes, and kidney disorders; A. judaica for gastrointestinal disorders; A. tripartite for sore throat, tonsillitis, cold, headache, and wounds; A. vulgaris as analgesic, anti-inflammatory, and antispasmodic; and A. verlotorum for hypertension (Bora and Sharma 2011).
Artemisinin is the major bioactive compound, which is rich in mono- and sesquiterpenes, and is a new class of potential antimalarial drug used throughout the globe. The combination therapies of artemisinin are considered to be the best treatment for Plasmodium falciparum malaria (He et al. 2009). Apart from antimalarial activity, the oil has antibacterial and antifungal (Bilia et al. 2014), immunosuppressive, anti-inflammatory, antioxidant (Cavar et al. 2012), and antiviral (Alesaeidi and Miraj 2016) activities. A. annua has also been studied against diabetes, heart diseases, arthritis, eczema, and cancer.
In vitro and in vivo studies on artemisinin have given good evidence of its anticancer activity. The mechanism of action of its antineoplastic activity has also been exhaustively studied and reviewed. Artemisinin is described to induce oxidative stress and nitric oxide production; cause DNA damage and repair; induce apoptosis, autophagy, and necrosis; and inhibit angiogenesis and mitogen-activated protein kinases (MAPK) pathway, metastatic pathway, etc. (Efferth 2017). Phase I and II clinical trials for the molecule have also been done; but hepatotoxicity caused by artemisinin combination therapy is a limitation as of now. The anticancer activity of artemisinin has been studied in breast cancer, in lung cancer, and in prostate carcinoma (Lai and Singh 2006; Sun et al. 2014; Michaelsen et al. 2015).
Drugs for treatment of malaria Artemisinin is the drug for the treatment of malaria with the most excellent efficacy, being a kind of sesquiterpene lactone containing peroxide group extracted from the traditional Chinese medicine Artemisia annua. It is characterized with high efficiency, rapid efficacy, clearing summer-heat, clearing deficiency heat, protozoa-killing effect and low toxicity. Currently, the efficacy of the artemisinin-based combination therapy (ACT) for the treatment of malaria worldwide has reached over 90%. ACT has been already widely applied to the treatment of malaria in many countries around the world. 
It has a strong and rapid killing effect on the erythrocytic stage of plasmodium, being able to rapidly control the clinical seizures and symptoms. Meanwhile, it also has prominent efficacy in the treatment of chicken coccidiosis, Mycoplasma Suis, toxoplasmosis, weakness and fever, damp heat jaundice, tertian malaria, falciparum malaria, cerebral malaria and chloroquine malaria. 
Artemisinin was first successfully developed by Chinese scientists, being effective monomer originated from the folk malaria-treatment herbs Artemisia annua. China is one of the major resource countries for the growth of such plants. The demands for research and development originated from the Vietnam War in 1960s when Malaria parasites had been resistant to special drug chloroquine at that time. In Vietnam War, many soldiers are not killed in the war, but instead died of malaria.
Because of the presence of artemisinin resistance in the border areas of Cambodia and Thailand, the World Health Organization advocates the use of combinations rather than monomeric formulation. In this environment, the world's first artemisinin-based compound antimalarial drug-compound artemether has been successfully developed in China. However, due to the lack of attention on the importance of intellectual property of Chinese pharmaceutical companies, currently in the world, only Novartis Company has the authority of foreign selling of artemether compound that has been recognized by the World Health Organization. The Novartis Company has offered the drug to the WHO at the cost price, wining the wide acclaim from international community. However, in this trade war, China can only play a role of major drug producing countries.
Chemical properties It appears as colorless needle crystal with a melting point being156-157 °C. It is easily soluble in chloroform, acetone, ethyl acetate and benzene, being soluble in methanol, ethanol and insoluble in water.
Uses Artemisia annua is used as antimalarial drugs. Clinical application has shown that artemisinin and its derivatives have special effects on treating the malaria and falciparum malaria, especially artemisinin which has stronger killing effect on Plasmodium falciparum intracellular phorozoon than other artemisinin drugs, characterized by high efficiency, rapid efficacy, low toxicity and no cross-resistance with chloroquine, etc. It can be not only used for treatment, but also for emergency treatment. It is applicable to a variety of malaria such as falciparum malaria, vivax malaria, anti-chloroquine malaria and cerebral malaria, including dangerous type. 
The most notable drug is dihydroartemisinin and its tablets. This drug has its antimalarial effect be 10 times as strong as artemisinin with the recurrence rate of only 1.95%, thus having been rated as China's top ten scientific and technological achievements in 1992. Artemisinin and its derivatives not only are excellent antimalarial drugs, but also have potentially attractive prospect in the treatment of other diseases. Animal experiments have found that artemisinin treatment of Clonorchis sinensis can achieve a rate of pest control being up to 100%; treatment of animal schistosomiasis can achieve a pest control rate of 33.8-99.3%. Application of artemisinin treatment of discoid lupus erythematosus can achieve a total effective rate of 90%. Its efficacy in the treatment of dengue fever is significantly better than moine biguanide and other western medicines. Immunologists have also found that artemisinin can significantly improve the lymphocyte transformation rate and enhance the immune function of antibodies. People haven't found toxic effect of this product on the heart, liver and kidney. People haven't observed any significant side effects in clinical practice.
Production method It can be extracted from the leaves of Artemisia annua L. (Compositae). In addition to artemisinin, China also produces both artemether and sodium artemisinin.
Category  Toxic substances
Toxic grading  Poisoning
Acute toxicity Intraperitoneal-rat LD50: 2571 mg/kg; Abdominal-mouse LD50: 1558 mg/kg
Flammability and Hazardous properties  it is combustible with combustion producing irritating fumes
Storage and transportation characteristics Ventilation, low temperature and dry;
Fire extinguishing agent dry powder, foam, sand, carbon dioxide, mist water
References 1. Luo XD, Shen CC (1987). The chemistry, pharmacology and clinical applications of qinghaosu (artemisinin) and its derivatives. Med Res Rev, 7, 29-52.
2. Klayman DL (1985). Qinghaosu (artemisinin): an antimalarial drug from China. Science, 228, 1049-1055.
3. Zhang F, Gosser Jr. DK, Meshnick SR (1992). Hemin-catalyzed decomposition of artemisinin (qinghaosu). Biochem Pharmacol, 43, 1805-1809.
4. Meshnick SR, Yang YZ, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y (1993). Irondependent free radical generation from the antimalarial artemisinin (qinghaosu). Antimicrob Agents Chemother, 37, 1108-1114.
5. The role of artemisinin and its derivatives in the current treatment of malaria (1994-1995). Report of an informal consultation convened by WHO, 27-29 September, 1993. (Geneva: World Health Organization).
6. Hien TT, White NJ (1993). Qinghaosu. Lancet, 341, 603-608.
7. Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH, Schuster BG (1994). Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg, 51, 251-259.
 
Description Artemisinin, a sesquiterpene isolated from a traditional Chinese remedy (quinghao), is useful in the treatment of Fafciparum malaria, including infections caused by chloroquine resistant strains. It is reported to clear parasitemia quicker than i.v. quinine, and is effective in cerebral malaria.
Chemical Properties Crystalline Solid
Originator Ping Hau Sau Res. Group (China)
Uses Active antimalarial constituent of the tradional Chinese medicinal herb Artemisia annua L., Compositae, which has been known for almost 2000 years as Qinghao. Antimalarial
Uses An antimalarial agent that inhibits F expression and NOS2.
Definition ChEBI: A sesquiterpene lactone obtained from sweet wormwood, Artemisia annua, which is used as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria.
Antimicrobial activity Artemisinins are active against the erythrocytic and gametocyte stages of chloroquine-sensitive and chloroquine-resistant strains of P. falciparum and other malaria parasites. Two anomers of artemether are produced on synthesis, α-artemether and β-artemether, of which the latter has higher antimalarial activity. Activity against the protozoa Tox. gondii and Leishmania major and the helminth Schistosoma mansoni has been demonstrated in experimental models.
Acquired resistance Resistance caused, for example, by changes in the plasmodial endoplasmic reticulum ATPase has been shown in experimental models. There have been clinical reports of reduced susceptibility to treatment with artesunate in Cambodia.
General Description The artemisinin series are the newest of the antimalarialdrugs and are structurally unique when comparedwith the compounds previously and currently used. Theparent compound, artemisinin, is a natural product extractedfrom the dry leaves of Artemisia Annua (sweetwormwood). The plant has to be grown each year fromseed because mature plants may lack the active drug. The growing conditions are critical to maximize artemisininyield. Thus far, the best yields have been obtained fromplants grown in North Vietnam, Chongqing province inChina, and Tanzania.
Pharmaceutical Applications A sesquiterpene peroxide derived from A. annua, chiefly used in the form of artemether, the methyl ester synthesized from dihydroartemisinin, or artesunate, the water-soluble hemisuccinate. Formulated for administration by the oral, intramuscular or intrarectal routes; artesunate can also be given intravenously.
Pharmaceutical Applications Artemisinin (qinghaosu), a compound derived from a plant used in traditional Chinese medicine, Artemisia annua, has been used extensively in East Asia and Africa for the treatment of malaria. This drug, and derivatives that have higher intrinsic antimalarial activity (artesunate, artemether and arteether), have replaced quinine as a treatment of falciparum malaria in many countries, normally in combination with other antimalarials. A semisynthetic derivative, artemisone, which has higher efficacy than artesunate and lower toxicity potential, is in development. Artemisinin and its derivatives also show broad antiprotozoal, anthelmintic and antiviral activities.
The novel structure, containing an endoperoxide bridge, has stimulated the development of semisynthetic and synthetic dioxane, trioxane and tetroxane compounds with activity against Plasmodium spp. and Schistosoma spp. Some of these synthetic trioxalanes are now in clinical development with Medicines for Malaria Venture and other organizations.
Biological Activity Antimalarial agent; interacts with heme to produce carbon-centred free radicals, causes protein alkylation and damages parasite microorganelles and membranes. Also selectively inhibits the P-type ATPase (PfATP6) of Plasmodium falciparum (K i ~ 150 nM). Displays antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies.
Pharmacokinetics Oral absorption: Incomplete
Cmax 500 mg oral: 0.4 mg/L after 1.8 h
Plasma half-life (dihydroartemisinin): 40-60 min
Volume of distribution: c. 0.25 L/kg
Plasma protein binding (artemether): 77%
Artemisinins are concentrated by erythrocytes and are rapidly hydrolyzed to dihydroartemisinin. They are hydroxylated by cytochromes 2B6, 2C19 and 3A4; the derivatives induce this metabolism. After injection, peak plasma concentrations are reached within 1-3 h, when levels of dihydroartemisinin are included. The elimination half-life of intravenous artesunate is <30 min; artemether appears to have a much longer half-life (4-11 h).
Clinical Use Malaria (including cerebral malaria), in combination with other antimalarials
Side effects A few toxic effects in addition to drug-induced fever and a reversible decrease in reticulocyte counts have been reported. High-dose studies in animal models show neurotoxicity and reproducible dose-related neuropathic lesions; dihydroartemisinin is a toxic metabolite but the precise causes of neurotoxicity are not clear. Embryotoxicity of artemisinin and derivatives has been reported in rodent and primate models, probably due to depletion of erythroblasts.
Safety Profile Moderately toxic by ingestion,intramuscular, and intraperitoneal routes. When heated todecomposition it emits acrid smoke and fumes.














Hunan JK International Trade Corporation / JK BIO-CHEM CO.,LTD is a professional exporter of food/feed additives and food /feed ingredients in China. With years of development, now we are able to provide the following food additives and food ingredients: thickeners, antioxidants, preservatives, vitamins, sweeteners, proteins, acidulants, nutritional supplements, flavours, coenzyme and so on.
Our food additives and food ingredients, especially our Ascorbic Acid (Vitamin C), Acesulfame-K, Aspartame, Citrates, Dextrose, D-Xylose, Erythorbic Acid, Fumaric Acid, Fructose,Maltodextrin, Malic Acid, Monosodium glutamate, Lactic Acid Potassium Sorbate, Sodium Erythorbate, Sodium Cyclamate, Sodium Saccharin, sodium benzoate, Sodium ascorbate, Sorbic Acid, xanthan Gum, Xylitol, Tartaric Acid, I+G, , Vanillin, Sucralose, Stevia and so on, have been exported to more than 60 countries for our good quality products.
Our staff of sales and technical support is available to help you in selecting the right protection for your application as well as to provide you with samples of our products for evaluation. At High Five, we are committed to providing the highest level of customer service, competitive pricing, speedy delivery and a comprehensive, cutting-edge product offering. Our ultimate goal is your satisfaction.





Packing&Shipping 

Artemisinin, Artemisia Annual L, Artemisinin 99%Artemisinin, Artemisia Annual L, Artemisinin 99%
FAQ

Q1.What's the payment terms?
We could accept T/T, L/C, DP payment terms.

Q2.How about the different index of products in same application?
Specifications can be customized according to your application.

Q3.How about the samples of products?
We can provide free samples under 2Kg(not including freight charge).

Q4.How about the price of products?
Our products are chemical synthesis got from underground brine, which is available for a variety of usage. Our products are high purity with good quality, and the price is based on different specification and quantity.

Q5.What's the shelf life for the cargoes?
Our product's shelf life is 2 years, which is based on dry and ventilated storage.

Q6.What's the package of the cargoes?
20kg/25kg woven bags, within plastic bags, or as customized.

Q7.What's the delivery time?
We usually deliver the cargoes within 10~20 days after receiving customer's payment or original L/C.


Q8.Which documents can we supply?
Commercial Invoice, Packing List, Certificate of Analysis, Certificate of Origin (FORM E), Bill of Loading, ISO etc.
The documents will be sent by Express within 24 hours against your full payment.

Q9.Why do you choose us?
We accept safe and diversified payment terms.
We supply a price trend to ensure clients know marketing information in time. We will take charge of 100% responsibility for
quality issue. We strive to create value for each customer we serve by meeting their unique needs and providing solutions to solve their problems and achieve their objectives.





Artemisinin, Artemisia Annual L, Artemisinin 99% Artemisinin, Artemisia Annual L, Artemisinin 99% Artemisinin, Artemisia Annual L, Artemisinin 99% Artemisinin, Artemisia Annual L, Artemisinin 99% Artemisinin, Artemisia Annual L, Artemisinin 99% Artemisinin, Artemisia Annual L, Artemisinin 99%




 

Send your message to this supplier

*From:
*To:
avatar Mr. Terry
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Contact Supplier

Gold Member Since 2019

Suppliers with verified business licenses

Rating: 5.0/5
Trading Company
Number of Employees
5
Year of Establishment
2017-12-29